AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] MarketWise, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Form 144 filed for Sight Sciences, Inc. (SGHT) discloses a contemplated insider disposition of 5,679 common shares through Fidelity Brokerage Services on 07 / 03 / 2025. At the most recent market price, the block is valued at $23,705.28. With 51,702,088 shares outstanding, the proposed sale equates to just 0.011 % of the float, suggesting minimal market impact.

The seller acquired the shares via restricted-stock vesting on 06 / 30 / 2025 as compensation. No other sales were reported in the past three months, and the filer attests to possessing no undisclosed adverse information. Under Rule 144, the notice creates a 90-day window in which the shares may be sold; actual execution will be confirmed, if it occurs, by a subsequent Form 4.

Although the dollar amount is immaterial in relation to SGHT’s capitalization, investors often view any insider sale as a potential sentiment signal. Monitoring future filings will clarify whether this event reflects routine liquidity or the start of a broader selling pattern.

Il modulo 144 presentato per Sight Sciences, Inc. (SGHT) segnala una prevista cessione da parte di un insider di 5.679 azioni ordinarie tramite Fidelity Brokerage Services il 07 / 03 / 2025. Al prezzo di mercato più recente, il blocco è valutato 23.705,28 $. Con 51.702.088 azioni in circolazione, la vendita proposta corrisponde a solo lo 0,011 % del flottante, suggerendo un impatto minimo sul mercato.

Il venditore ha acquisito le azioni tramite vesting di azioni vincolate il 30 / 06 / 2025 come compenso. Negli ultimi tre mesi non sono state segnalate altre vendite e il dichiarante attesta di non possedere informazioni negative non divulgate. Ai sensi della Regola 144, l’avviso crea una finestra di 90 giorni entro cui le azioni possono essere vendute; l’effettiva esecuzione sarà confermata, se avverrà, da un successivo modulo 4.

Nonostante l’importo in dollari sia irrilevante rispetto alla capitalizzazione di SGHT, gli investitori spesso interpretano qualsiasi vendita da parte di insider come un possibile segnale di sentiment. Monitorare le future comunicazioni chiarirà se questo evento rappresenta una liquidità di routine o l’inizio di un più ampio pattern di vendita.

El formulario 144 presentado para Sight Sciences, Inc. (SGHT) revela una prevista disposición interna de 5,679 acciones comunes a través de Fidelity Brokerage Services el 07 / 03 / 2025. Al precio de mercado más reciente, el bloque está valorado en $23,705.28. Con 51,702,088 acciones en circulación, la venta propuesta equivale a solo el 0.011 % del flotante, lo que sugiere un impacto mínimo en el mercado.

El vendedor adquirió las acciones mediante vesting de acciones restringidas el 30 / 06 / 2025 como compensación. No se reportaron otras ventas en los últimos tres meses y el declarante asegura no poseer información adversa no divulgada. Bajo la Regla 144, el aviso crea una ventana de 90 días durante la cual las acciones pueden venderse; la ejecución real se confirmará, si ocurre, mediante un formulario 4 posterior.

Aunque el monto en dólares es insignificante en relación con la capitalización de SGHT, los inversores a menudo consideran cualquier venta interna como una posible señal de sentimiento. El seguimiento de futuras presentaciones aclarará si este evento refleja liquidez rutinaria o el inicio de un patrón de venta más amplio.

Sight Sciences, Inc. (SGHT)ì—� 대í•� 제출ë� 144ì–‘ì‹ì€ 2025ë…� 7ì›� 3ì� Fidelity Brokerage Servicesë¥� 통해 5,679ì£� 보통ì£�ì� ë‚´ë¶€ìž� ë§¤ê° ì˜ˆì • 사실ì� 공개합니ë‹�. 최근 시장 ê°€ê²� 기준으로 해당 ì£¼ì‹ ê°€ì¹˜ëŠ” 23,705.28달러입니ë‹�. ì´� 51,702,088주가 유통 ì¤‘ì¸ ê°€ìš´ë°, 제안ë� ë§¤ê° ê·œëª¨ëŠ� 유통 주ì‹ì� 단지 0.011 %ì—� 불과하여 시장ì—� 미치ëŠ� ì˜í–¥ì� 미미í•� 것으ë¡� 보입니다.

매ë„ìžëŠ” ë³´ìƒ ì°¨ì›ì—서 제한 ì£¼ì‹ ê¶Œë¦¬ 확정(vesting)ì� 통해 2025ë…� 6ì›� 30ì¼ì— 주ì‹ì� ì·¨ë“했습니다. 최근 3개월ê°� 다른 ë§¤ê° ë³´ê³ ëŠ� 없었으며, 제출ìžëŠ” 미공ê°� ë¶€ì •ì  ì •ë³´ê°€ ì—†ìŒì� 진술했습니다. 규칙 144ì—� ë”°ë¼ ì� 통지ëŠ� 주ì‹ì� 매ë„í•� ìˆ� 있는 90ì� 기간ì� ìƒì„±í•˜ë©°, 실제 매ê°ì� ì´ë£¨ì–´ì§ˆ 경우 ì´í›„ 제출ë˜ëŠ” 4ì–‘ì‹ì� 통해 확ì¸ë©ë‹ˆë‹�.

금액ì� SGHTì� ìžë³¸ 규모ì—� 비해 미미하지ë§�, 투ìžìžë“¤ì€ ë‚´ë¶€ìž� 매ê°ì� 잠재ì ì¸ 시장 심리 신호ë¡� 보는 경향ì� 있습니다. 향후 제출 서류ë¥� 모니터ë§í•˜ë©´ ì´ë²ˆ 사건ì� ì¼ìƒì ì¸ 유ë™ì„� 확보ì¸ì§€ 아니ë©� ë� 광범위한 ë§¤ë„ íŒ¨í„´ì� 시작ì¸ì§€ 명확해질 것입니다.

Le formulaire 144 déposé pour Sight Sciences, Inc. (SGHT) révèle une cession envisagée par un initié de 5 679 actions ordinaires via Fidelity Brokerage Services le 07 / 03 / 2025. Au dernier cours du marché, ce bloc est valorisé à 23 705,28 $. Avec 51 702 088 actions en circulation, la vente proposée représente seulement 0,011 %

Le vendeur a acquis les actions par vesting d’actions restreintes le 30 / 06 / 2025 en guise de rémunération. Aucune autre vente n’a été signalée au cours des trois derniers mois et le déclarant affirme ne détenir aucune information défavorable non divulguée. En vertu de la règle 144, cet avis crée une fenêtre de 90 jours pendant laquelle les actions peuvent être vendues ; l’exécution effective sera confirmée, si elle a lieu, par un formulaire 4 ultérieur.

Bien que le montant en dollars soit insignifiant par rapport à la capitalisation de SGHT, les investisseurs considèrent souvent toute vente par un initié comme un signal potentiel de sentiment. Le suivi des prochains dépôts permettra de déterminer si cet événement reflète une liquidité de routine ou le début d’un schéma de vente plus large.

Das eingereichte Formular 144 für Sight Sciences, Inc. (SGHT) offenbart einen geplanten Insider-Verkauf von 5.679 Stammaktien über Fidelity Brokerage Services am 07 / 03 / 2025. Zum zuletzt bekannten Marktpreis beläuft sich der Wert des Blocks auf 23.705,28 $. Bei insgesamt 51.702.088 ausstehenden Aktien entspricht der vorgeschlagene Verkauf nur 0,011 % des Free Floats, was auf eine minimale Marktbeeinflussung hindeutet.

Der Verkäufer erwarb die Aktien durch Restricted-Stock-Vesting am 30 / 06 / 2025 als Vergütung. In den letzten drei Monaten wurden keine weiteren Verkäufe gemeldet, und der Einreicher bestätigt, keine nicht offengelegten negativen Informationen zu besitzen. Gemäß Regel 144 schafft die Meldung ein 90-tägiges Fenster, in dem die Aktien verkauft werden können; eine tatsächliche Ausführung wird, falls sie erfolgt, durch ein nachfolgendes Formular 4 bestätigt.

Obwohl der Dollarbetrag im Verhältnis zur Kapitalisierung von SGHT unerheblich ist, sehen Investoren Insider-Verkäufe oft als potenzielles Stimmungsbarometer. Die Beobachtung zukünftiger Meldungen wird klären, ob es sich hierbei um routinemäßige Liquidität oder den Beginn eines umfassenderen Verkaufsverhaltens handelt.

Positive
  • Very small sale size—only 0.011 % of shares outstanding, limiting dilution or price impact.
Negative
  • Insider intent to sell could be perceived negatively by some investors despite the modest amount.

Insights

TL;DR Small Form 144 filing; volume immaterial and unlikely to pressure SGHT shares.

The proposed transaction involves fewer than 6 thousand shares—an insignificant 0.011 % of the company’s outstanding stock. Valued below $25 thousand, it should not affect liquidity or price discovery. Rule 144 merely signals intent; a Form 4 is required to confirm execution and pricing. Given the lack of accompanying negative news, I consider the filing neutral for the investment thesis.

TL;DR Routine liquidity move; no governance red flags detected.

The shares stem from recent restricted-stock vesting, so the sale looks like a standard diversification decision. The filer certifies no access to undisclosed adverse information, and the absence of clustered sales over the prior three months reduces the risk of a bearish insider trend. Still, governance best practice calls for ongoing monitoring to ensure cumulative insider activity remains immaterial.

Il modulo 144 presentato per Sight Sciences, Inc. (SGHT) segnala una prevista cessione da parte di un insider di 5.679 azioni ordinarie tramite Fidelity Brokerage Services il 07 / 03 / 2025. Al prezzo di mercato più recente, il blocco è valutato 23.705,28 $. Con 51.702.088 azioni in circolazione, la vendita proposta corrisponde a solo lo 0,011 % del flottante, suggerendo un impatto minimo sul mercato.

Il venditore ha acquisito le azioni tramite vesting di azioni vincolate il 30 / 06 / 2025 come compenso. Negli ultimi tre mesi non sono state segnalate altre vendite e il dichiarante attesta di non possedere informazioni negative non divulgate. Ai sensi della Regola 144, l’avviso crea una finestra di 90 giorni entro cui le azioni possono essere vendute; l’effettiva esecuzione sarà confermata, se avverrà, da un successivo modulo 4.

Nonostante l’importo in dollari sia irrilevante rispetto alla capitalizzazione di SGHT, gli investitori spesso interpretano qualsiasi vendita da parte di insider come un possibile segnale di sentiment. Monitorare le future comunicazioni chiarirà se questo evento rappresenta una liquidità di routine o l’inizio di un più ampio pattern di vendita.

El formulario 144 presentado para Sight Sciences, Inc. (SGHT) revela una prevista disposición interna de 5,679 acciones comunes a través de Fidelity Brokerage Services el 07 / 03 / 2025. Al precio de mercado más reciente, el bloque está valorado en $23,705.28. Con 51,702,088 acciones en circulación, la venta propuesta equivale a solo el 0.011 % del flotante, lo que sugiere un impacto mínimo en el mercado.

El vendedor adquirió las acciones mediante vesting de acciones restringidas el 30 / 06 / 2025 como compensación. No se reportaron otras ventas en los últimos tres meses y el declarante asegura no poseer información adversa no divulgada. Bajo la Regla 144, el aviso crea una ventana de 90 días durante la cual las acciones pueden venderse; la ejecución real se confirmará, si ocurre, mediante un formulario 4 posterior.

Aunque el monto en dólares es insignificante en relación con la capitalización de SGHT, los inversores a menudo consideran cualquier venta interna como una posible señal de sentimiento. El seguimiento de futuras presentaciones aclarará si este evento refleja liquidez rutinaria o el inicio de un patrón de venta más amplio.

Sight Sciences, Inc. (SGHT)ì—� 대í•� 제출ë� 144ì–‘ì‹ì€ 2025ë…� 7ì›� 3ì� Fidelity Brokerage Servicesë¥� 통해 5,679ì£� 보통ì£�ì� ë‚´ë¶€ìž� ë§¤ê° ì˜ˆì • 사실ì� 공개합니ë‹�. 최근 시장 ê°€ê²� 기준으로 해당 ì£¼ì‹ ê°€ì¹˜ëŠ” 23,705.28달러입니ë‹�. ì´� 51,702,088주가 유통 ì¤‘ì¸ ê°€ìš´ë°, 제안ë� ë§¤ê° ê·œëª¨ëŠ� 유통 주ì‹ì� 단지 0.011 %ì—� 불과하여 시장ì—� 미치ëŠ� ì˜í–¥ì� 미미í•� 것으ë¡� 보입니다.

매ë„ìžëŠ” ë³´ìƒ ì°¨ì›ì—서 제한 ì£¼ì‹ ê¶Œë¦¬ 확정(vesting)ì� 통해 2025ë…� 6ì›� 30ì¼ì— 주ì‹ì� ì·¨ë“했습니다. 최근 3개월ê°� 다른 ë§¤ê° ë³´ê³ ëŠ� 없었으며, 제출ìžëŠ” 미공ê°� ë¶€ì •ì  ì •ë³´ê°€ ì—†ìŒì� 진술했습니다. 규칙 144ì—� ë”°ë¼ ì� 통지ëŠ� 주ì‹ì� 매ë„í•� ìˆ� 있는 90ì� 기간ì� ìƒì„±í•˜ë©°, 실제 매ê°ì� ì´ë£¨ì–´ì§ˆ 경우 ì´í›„ 제출ë˜ëŠ” 4ì–‘ì‹ì� 통해 확ì¸ë©ë‹ˆë‹�.

금액ì� SGHTì� ìžë³¸ 규모ì—� 비해 미미하지ë§�, 투ìžìžë“¤ì€ ë‚´ë¶€ìž� 매ê°ì� 잠재ì ì¸ 시장 심리 신호ë¡� 보는 경향ì� 있습니다. 향후 제출 서류ë¥� 모니터ë§í•˜ë©´ ì´ë²ˆ 사건ì� ì¼ìƒì ì¸ 유ë™ì„� 확보ì¸ì§€ 아니ë©� ë� 광범위한 ë§¤ë„ íŒ¨í„´ì� 시작ì¸ì§€ 명확해질 것입니다.

Le formulaire 144 déposé pour Sight Sciences, Inc. (SGHT) révèle une cession envisagée par un initié de 5 679 actions ordinaires via Fidelity Brokerage Services le 07 / 03 / 2025. Au dernier cours du marché, ce bloc est valorisé à 23 705,28 $. Avec 51 702 088 actions en circulation, la vente proposée représente seulement 0,011 %

Le vendeur a acquis les actions par vesting d’actions restreintes le 30 / 06 / 2025 en guise de rémunération. Aucune autre vente n’a été signalée au cours des trois derniers mois et le déclarant affirme ne détenir aucune information défavorable non divulguée. En vertu de la règle 144, cet avis crée une fenêtre de 90 jours pendant laquelle les actions peuvent être vendues ; l’exécution effective sera confirmée, si elle a lieu, par un formulaire 4 ultérieur.

Bien que le montant en dollars soit insignifiant par rapport à la capitalisation de SGHT, les investisseurs considèrent souvent toute vente par un initié comme un signal potentiel de sentiment. Le suivi des prochains dépôts permettra de déterminer si cet événement reflète une liquidité de routine ou le début d’un schéma de vente plus large.

Das eingereichte Formular 144 für Sight Sciences, Inc. (SGHT) offenbart einen geplanten Insider-Verkauf von 5.679 Stammaktien über Fidelity Brokerage Services am 07 / 03 / 2025. Zum zuletzt bekannten Marktpreis beläuft sich der Wert des Blocks auf 23.705,28 $. Bei insgesamt 51.702.088 ausstehenden Aktien entspricht der vorgeschlagene Verkauf nur 0,011 % des Free Floats, was auf eine minimale Marktbeeinflussung hindeutet.

Der Verkäufer erwarb die Aktien durch Restricted-Stock-Vesting am 30 / 06 / 2025 als Vergütung. In den letzten drei Monaten wurden keine weiteren Verkäufe gemeldet, und der Einreicher bestätigt, keine nicht offengelegten negativen Informationen zu besitzen. Gemäß Regel 144 schafft die Meldung ein 90-tägiges Fenster, in dem die Aktien verkauft werden können; eine tatsächliche Ausführung wird, falls sie erfolgt, durch ein nachfolgendes Formular 4 bestätigt.

Obwohl der Dollarbetrag im Verhältnis zur Kapitalisierung von SGHT unerheblich ist, sehen Investoren Insider-Verkäufe oft als potenzielles Stimmungsbarometer. Die Beobachtung zukünftiger Meldungen wird klären, ob es sich hierbei um routinemäßige Liquidität oder den Beginn eines umfassenderen Verkaufsverhaltens handelt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Forney Scott Daniel

(Last) (First) (Middle)
C/O MARKETWISE
1125 N. CHARLES STREET

(Street)
BALTIMORE MD 21201

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MARKETWISE, INC. [ MKTW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/01/2025 F 719(1) D $19.82 19,315(2)(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction is not a sale of shares by the Reporting Person. This represents shares that have been withheld by the Issuer to satisfy its tax withholdings and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
2. Includes 1,191 shares of Class A Common Stock acquired pursuant to the Issuer's employee stock purchase plan on June 30, 2025.
3. Effective April 2, 2025, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Remarks:
/s/ Scott D. Forney 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Marketwise Inc

NASDAQ:MKTW

MKTW Rankings

MKTW Latest News

MKTW Latest SEC Filings

MKTW Stock Data

52.10M
1.86M
21.93%
23.81%
3.57%
Financial Data & Stock Exchanges
Services-prepackaged Software
United States
NEW YORK